A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery-Reference-Cited by-同舟云学术

A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery

Published:2020-06 Issue:6 Volume:21 Page:792-796
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Hesterberg Kirstin,Rawal Aranyak,Khan Sajjad,Rashid Abdul,Jones David,Siddiqui Tariq,Khader Thekrayat A.,Nayyar Manu,Shah Rahman

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference33 articles.

1. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial;Mohr;Lancet (London, England),2013

2. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM Follow-On Study;Farkouh;J Am Coll Cardiol,2019

3. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV;Hess;Circulation.,2014

4. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association;Kulik;Circulation.,2015

5. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study;Goldman;Circulation.,1989

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial;American Heart Journal;2023-05

2. Acute Coronary Syndromes Among Patients with Prior Coronary Artery Bypass Surgery;Current Cardiology Reports;2022-09-12

3. Therapeutic-Dose Warfarin (International Normalized Ratio >1.6) Plus Aspirin Improved Long-Term Patency of Saphenous Vein Graft without Bleeding Complication;Annals of Thoracic and Cardiovascular Surgery;2022

4. Early and annual outcomes of coronary artery bypass grafting in patients with coronary arteries less than 1.5 mm and their comparison with postoperative outcomes in patients with larger coronary arteries;Kardiologicheskii vestnik;2022

5. Atrial fibrillation following coronary artery bypass graft: Where do we stand?;Cardiovascular Revascularization Medicine;2021-12